News Current page: 15

Incision is rapidly expanding its platform for surgical performance and online training The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion of Incision Group’s international business Operating room staff and surgical residents from over 200 hospitals in more than 18 countries now use […]

Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system.

ntv reported in an exciting TV report about Mental Health Apps with focus on the DiGa of the SHS portfolio company Selfapy GmbH. It shows that digital therapies are increasingly arriving in mainstream care. Especially in the pandemic, low-threshold digital solutions are a great added value for patients.

Despite the Corona pandemic, the high-tech company Tyromotion GmbH reports considerable success. Tyromotion develops state-of-the-art rehabilitation devices, among others for MS patients and stroke patients. Thanks to state-of-the-art robotics, sensor technology and virtual reality, the rehabilitation process becomes more intensive and the patient sees successes more quickly. The concept also convinced customers in Australia, where […]

Neuro Event Labs Oy is a leading healthtech company in the field of AI-based diagnosis and monitoring of epilepsy patients. Now the SHS portfolio company announces an extensive cooperation with Filadelfia Epilepsy Hospital in Dianalund. The renowned specialist clinic for epilepsy patients in western Denmark will use the AI-based diagnostic tool Nelli Pro on all […]

The successful specialty pharmaceutical company AMW GmbH is expanding its management team and bringing experience and leadership to its new CEO, Dr. Konstantin Petropoulus. With his many years of expertise, the molecular biologist with an MBA is to help strengthen AMW’s global presence. In addition, Dr. Petropoulus will expand the drug delivery system pipeline with […]

With the internationally recognised EXCiPACT certification, the globally successful biotech company c-LEcta GmbH from Leipzig receives confirmation of its high quality standards in production and distribution (GMP and GDP). The certificate is recognised worldwide by relevant authorities such as the European Union (EU), the US Food and Drug Administration (FDA) and the UK Medicines and […]

With pulsed and CW laser systems in the deep UV range, Crystal Laser Systems GmbH enjoys a very good reputation worldwide in the healthcare, biotech and semiconductor sectors. SHS is selling the profitable and rapidly growing company to the investor SIP, which intends to further strengthen the market position of CryLaS with new products and […]

In a podcast, André Zimmermann explains what the MDR is all about and answers this question: “Is Europe and its MDR killing Medtech Innovation? “. EIT Health is an EU-funded “Knowledge and Innovation Community of the European Institute of Innovation and Technology (EIT)”. Its aim is to promote high-performance health systems and a sustainable health […]

SHS offers students from various disciplines the opportunity to complete an internship during their studies. In this way, SHS gives young, motivated people a practical insight into the areas of growth capital and private equity. SHS sees this as an important contribution to the professional development of future top performers. We are pleased to welcome […]

numares AG, a leader in NMR metabolomics-based diagnostics, has developed a novel multi-marker approach – GFRNMR – to determine kidney function using simple serum tests. The combination of multiple renal biomarkers can exceed the diagnostic limitations of the established method for estimating GFR (glomerular filtration rate). The assessment of kidney function is extremely important for […]

“OPN-NC Super High Pressure PTCA-Balloon” is the name of the high-pressure balloon catheter from the Swiss company SIS Medical AG, which achieved comparable, often even higher stent expansion compared to conventional balloon catheters in a successfully completed study on 74 heart patients. At the same time, the treatment success can be achieved in only one […]